Schneider National (NYSE:SNDR – Get Free Report) will post its quarterly earnings results before the market opens on Wednesday, November 6th. Analysts expect Schneider National to post earnings of $0.23 per share for the quarter. Individual that wish to listen to the company’s earnings conference call can do so using this link.
Schneider National Trading Up 0.6 %
Shares of NYSE:SNDR opened at $28.57 on Tuesday. The company has a market cap of $5.01 billion, a PE ratio of 43.95, a P/E/G ratio of 2.88 and a beta of 0.85. The company’s 50-day moving average price is $27.67 and its 200 day moving average price is $25.08. Schneider National has a fifty-two week low of $20.50 and a fifty-two week high of $29.18. The company has a quick ratio of 1.46, a current ratio of 1.59 and a debt-to-equity ratio of 0.04.
Schneider National Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 8th. Investors of record on Friday, December 13th will be given a $0.095 dividend. The ex-dividend date of this dividend is Friday, December 13th. This represents a $0.38 annualized dividend and a yield of 1.33%. Schneider National’s dividend payout ratio is presently 58.46%.
Analyst Ratings Changes
Check Out Our Latest Stock Analysis on SNDR
Schneider National Company Profile
Schneider National, Inc, together with its subsidiaries, provides surface transportation and logistics solutions in the United States, Canada, and Mexico. It operates through three segments: Truckload, Intermodal, and Logistics. The Truckload segment offers over the road freight transportation services primarily through dry van, bulk, temperature-controlled, and flat-bed trailers across either network or dedicated configurations.
Featured Stories
- Five stocks we like better than Schneider National
- Why Are Stock Sectors Important to Successful Investing?
- Intel: Is Now the Time to Be Brave?
- Profitably Trade Stocks at 52-Week Highs
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- 3 Healthcare Dividend Stocks to Buy
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for Schneider National Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Schneider National and related companies with MarketBeat.com's FREE daily email newsletter.